Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Andrews

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Human Vaccines & Immunotherapeutics|November 20, 2025
Neonatal and infant mortality after maternal influenza and pertussis vaccination: Probabilistically linked cohort studyMohinder Sarna, Christopher C Blyth, Hannah C Moore, et al.
Vaccine|April 30, 2017
Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsivenessSarah Moberley, Paul V Licciardi, Anne Balloch, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji TrialLucia Romani, Margot J Whitfeld, Josefa Koroivueta, et al.
Communicable Diseases Intelligence Quarterly Report|October 29, 2004
Invasive pneumococcal disease in Australia, 2002Paul Roche, Vicki Krause, Ross Andrews, et al.
Plos Medicine|August 3, 2021
Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational studyJocelyn Chan, Heather F Gidding, Christopher C Blyth, et al.
BMJ Open|November 16, 2019
The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritisBianca Fleur Middleton, Mark A Jones, Claire S Waddington, et al.
Plos Neglected Tropical Diseases|February 22, 2021
Defining the need for public health control of scabies in Solomon IslandsSusanna J Lake, Daniel Engelman, Oliver Sokana, et al.
Pediatrics|October 9, 2023
Maternal Pertussis Vaccination, Infant Immunization, and Risk of PertussisAnnette K Regan, Hannah C Moore, Michael J Binks, et al.
BMJ Open|January 18, 2015
Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathu Santosham, et al.
Journal of Medical Virology|October 11, 2021
Transplacental transfer of RSV antibody in Australian First Nations infantsNusrat Homaira, Michael Binks, Gregory Walker, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Human Vaccines & Immunotherapeutics|November 20, 2025
Neonatal and infant mortality after maternal influenza and pertussis vaccination: Probabilistically linked cohort studyMohinder Sarna, Christopher C Blyth, Hannah C Moore, et al.
Vaccine|April 30, 2017
Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsivenessSarah Moberley, Paul V Licciardi, Anne Balloch, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji TrialLucia Romani, Margot J Whitfeld, Josefa Koroivueta, et al.
Communicable Diseases Intelligence Quarterly Report|October 29, 2004
Invasive pneumococcal disease in Australia, 2002Paul Roche, Vicki Krause, Ross Andrews, et al.
Plos Medicine|August 3, 2021
Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational studyJocelyn Chan, Heather F Gidding, Christopher C Blyth, et al.
BMJ Open|November 16, 2019
The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritisBianca Fleur Middleton, Mark A Jones, Claire S Waddington, et al.
Plos Neglected Tropical Diseases|February 22, 2021
Defining the need for public health control of scabies in Solomon IslandsSusanna J Lake, Daniel Engelman, Oliver Sokana, et al.
Pediatrics|October 9, 2023
Maternal Pertussis Vaccination, Infant Immunization, and Risk of PertussisAnnette K Regan, Hannah C Moore, Michael J Binks, et al.
BMJ Open|January 18, 2015
Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathu Santosham, et al.
Journal of Medical Virology|October 11, 2021
Transplacental transfer of RSV antibody in Australian First Nations infantsNusrat Homaira, Michael Binks, Gregory Walker, et al.
Pageof 6